Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 26-2454734 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To fund research to find treatments and cures for neuroblastoma cancer and to promote and develop enhanced awareness and advocacy support.
Principal Officer
Silvia Dominguez-Vanni
Total Revenue
$92K
FY2024
Total Expenses
$116K
FY2024
Net Assets
$221K
Program Ratio
97.9%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.